Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
48.83
56.51
54.35
46.50
35.17
38.28
39.89
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
48.83
56.51
54.35
46.50
35.17
38.28
39.89
Raw Material Cost
25.91
27.28
27.43
18.55
17.30
19.64
16.19
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-7.08
0.09
-1.38
5.40
-2.29
-1.30
1.32
Employee Cost
9.44
8.53
7.38
7.01
6.94
6.67
6.50
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
10.85
9.77
11.60
6.80
8.65
8.42
8.12
Total Expenditure (Excl Depreciation)
39.12
45.67
45.03
37.76
30.60
33.43
32.13
Operating Profit (PBDIT) excl Other Income
9.71
10.84
9.32
8.74
4.57
4.85
7.76
Other Income
2.11
1.26
1.32
0.72
1.38
1.59
0.32
Operating Profit (PBDIT)
11.82
12.10
10.64
9.46
5.95
6.44
8.08
Interest
0.24
0.26
0.22
0.20
0.08
0.15
0.27
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
11.58
11.84
10.42
9.26
5.87
6.29
7.81
Depreciation
1.30
1.27
1.21
1.15
0.84
1.18
1.10
Profit Before Tax
10.28
10.56
9.22
8.11
5.03
5.10
6.72
Tax
3.73
2.69
2.36
1.95
1.26
1.30
1.71
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6.56
7.87
6.86
6.16
3.77
3.80
5.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6.56
7.87
6.86
6.16
3.77
3.80
5.00
Share in Profit of Associates
0.17
0.66
0.90
0.70
0.28
0.59
1.69
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6.73
8.53
7.76
6.86
4.05
4.39
6.70
Equity Capital
8.26
8.26
8.26
8.26
8.26
8.26
8.26
Face Value
2.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
1.63
2.07
9.39
8.31
0.98
5.31
8.11
Diluted Earnings per share
1.63
2.06
9.4
8.3
0.98
5.31
8.1
Operating Profit Margin (Excl OI)
19.89%
19.18%
17.15%
18.8%
12.99%
12.67%
19.45%
Gross Profit Margin
23.71%
20.95%
19.17%
19.91%
16.69%
16.43%
19.58%
PAT Margin
13.43%
13.93%
12.62%
13.25%
10.72%
9.93%
12.53%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 38.84% vs -11.90% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 66.17% vs -19.00% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 112.47% vs -35.45% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is 200.00% vs -76.47% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Titan Biotech With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
48.83
341.61
-292.78
-85.71%
Other Operating Income
0.00
0.00
0.00
Total Operating income
48.83
341.61
-292.78
-85.71%
Raw Material Cost
25.91
203.60
-177.69
-87.27%
Purchase of Finished goods
0.00
16.27
-16.27
-100.00%
(Increase) / Decrease In Stocks
-7.08
-4.35
-2.73
-62.76%
Employee Cost
9.44
17.05
-7.61
-44.63%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
10.85
44.95
-34.10
-75.86%
Total Expenditure (Excl Depreciation)
39.12
277.52
-238.40
-85.90%
Operating Profit (PBDIT) excl Other Income
9.71
64.09
-54.38
-84.85%
Other Income
2.11
10.24
-8.13
-79.39%
Operating Profit (PBDIT)
11.82
74.33
-62.51
-84.10%
Interest
0.24
0.05
0.19
380.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
11.58
74.28
-62.70
-84.41%
Depreciation
1.30
2.00
-0.70
-35.00%
Profit Before Tax
10.28
72.20
-61.92
-85.76%
Tax
3.73
20.60
-16.87
-81.89%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
6.56
51.68
-45.12
-87.31%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
6.56
51.68
-45.12
-87.31%
Share in Profit of Associates
0.17
-0.08
0.25
312.50%
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.73
51.60
-44.87
-86.96%
Equity Capital
8.26
24.89
-16.63
-66.81%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
1.63
2.07
-0.44
-21.26%
Diluted Earnings per share
1.63
2.07
-0.44
-21.26%
Operating Profit Margin (Excl OI)
19.89%
18.76%
0.00
1.13%
Gross Profit Margin
23.71%
21.74%
0.00
1.97%
PAT Margin
13.43%
15.10%
0.00
-1.67%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 48.83 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -13.59% vs 3.97% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 38.84% vs -11.90% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.73 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -21.10% vs 9.92% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 66.17% vs -19.00% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.71 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -10.42% vs 16.31% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 112.47% vs -35.45% in Mar 2025
Quarterly - Interest
Interest 0.24 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -7.69% vs 18.18% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 200.00% vs -76.47% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.89%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
